Robert E. Reiter, MD, MBA, Author at Grand Rounds in Urology

Robert E. Reiter, MD, MBA

University of California, Los Angeles

Los Angeles, California

Robert E. Reiter, MD, MBA, is the Bing Professor of Urologic Oncology and a Professor of Molecular Biology at the University of California, Los Angeles. Dr. Reiter also serves as the Director of the Prostate Cancer Program and of Urologic Research, as Chief of the Division of Urologic Oncology, and as Co-Director of the Genitourinary Oncology Program for the Jonsson Cancer Center at the University of California, Los Angeles. He is an internationally recognized expert in all areas of prostate cancer management and research. Dr. Reiter has a particular interest in the multidisciplinary management of men with high-risk prostate cancer, incorporating the latest in genomics, clinical trials, and precision medical therapies into treatment plans.

Dr. Reiter earned his medical degree and completed a residency in Urology at Stanford University in Palo Alto, California. He then completed a residency in Urology at Baylor College of Medicine in Houston, Texas. Dr. Reiter subsequently completed a fellowship in Urologic Cancer at the National Cancer Institute. During his time there, he was awarded the Outstanding Achievement Award by the Urologic Oncology branch of the National Cancer Institute.

Dr. Reiter has expertise in MRI-guided biopsies to diagnose prostate cancer and focal therapy to treat select individuals, as well as all forms of medical therapy. He was among the first to integrate functional MRI imaging and PSMA PET imaging into the diagnosis, surgical management, and care of men with prostate cancer. He was also an early innovator in the field of robotic surgery and has completed more than 2,500 robotic prostatectomies. Dr. Reiter’s laboratory discovered the prostate stem cell antigen and developed antibodies to target this protein, which led to novel imaging and therapeutic approaches for prostate cancer currently in clinical trials. He has authored more than 250 papers and lectures nationally and internationally on all aspects of clinical care of men with prostate cancer.

Talks by Robert E. Reiter, MD, MBA

PSMA Imaging: Beyond MRI in Prostate Cancer

Robert E. Reiter, MD, MBA | Oct 2018

Robert E. Reiter, MD, provides a brief update on the benefits of prostate-specific membrane antigen (PSMA) imaging for staging and detecting prostate cancer, as well as the emergence of PSMA imaging in the United States.

The Role of Molecular Imaging in Managing High Risk and Recurrent Prostate Cancer

Robert E. Reiter, MD, MBA | Apr 2018

Robert E. Reiter, MD, summarizes the impact advanced imaging techniques have had on staging and managing prostate cancer in the past few years. He discusses state-of-the-art molecular imaging, particularly focusing on prostate-specific membrane antigen (PSMA) targeted imaging.

The Ups and Downs of MRI Interrogation of the Gland

Robert E. Reiter, MD, MBA | Mar 2018

Robert Reiter, MD, discusses the uses of MRI in prostate cancer management, especially its ability to predict biochemical recurrence (BCR). He also explains the difference between mapping and targeted biopsies, and how MRI suspicion score and tumor volume are associated with grade, stage, and recurrence of disease.